Fritextsökning
Innehållstyper
-
Rising interest in CRISPR treatments
Treatments using CRISPR technology are emerging as one of the hottest medical trends in the United States – and the FDA is doing its best to promote the development.
-
Anna Törner: ”Orphan Designation – the "petite robe noire" of drug development”
It is easy to cling to various regulatory incentives, like orphan designation, and other expedited pathways, without understanding what they truly mean or wheth...
-
Product demo with features, software and best-practices
Get interesting insights about ZEISS O-INSPECT duo in our demo recording.
-
Delivering drugs with small devices
There are many challenges to overcome when delivering a drug orally. Getting the drug to survive the low pH of the ventricle and being released at the correct s...
-
A green nursery for biotech rooted in the Scanian soil
Red Glead has established itself as one of Lund’s largest companies in pharmaceutical development. Life Science Sweden went to Skåne and met two of the founders...
-
Study: Popular diabetes treatment is not associated with thyroid cancer
Concerns raised about an association between GLP-1 analogues, used to treat diabetes and obesity, and an increased risk of thyroid cancer are not supported by a...
-
AI speeds up measurement process
How to inspect coatings ten times faster with a light microscope? The medical technology group Smith+Nephew has been using ZEISS Axio Imager.Z2m since summer 2022.
-
Quotient Sciences Limited
-
Zelmic
-
Anna Törner: The clinical trial – Periscope to reality
What happens to the patients in the clinical trial is not very interesting, writes Anna Törner in a column.
-
No longer afraid of the dentist.
Teaching robot with piezo technology
-
AI-Driven Microscopy Image Analysis in Pharma and Biotech
Extract breakthrough discoveries from large, complex data sets.
-
Galenica AB
-
Metabolon
-
Galderma
-
Great Swedish innovations: Eye treatment became a feather in Pharmacia’s cap
From complicated and sometimes risky surgery to a routine procedure. Pharmacia’s injectable Healon revolutionised the field of eye surgery - and is considered b...
-
Introducing ZEISS arivis Pro 4.2
Your solution for advanced image analysis and visualization.
-
Acquisition of consulting company Key2Compliance
The Swedish company Key2Compliance, offering services in fields such as pharma and Medtech, has been acquired by German GBA Group.
-
ZEISS presents the "Quality Innovation Days"
The digital event for metrology and software.
-
Improved processes and more
Discover the full potential and benefits.
-
Fullt godkännande i EU för Calliditas njurläkemedel – "Viktig händelse"
Calliditas läkemedel Kinpeygo har fått ett fullständigt godkännande från EU-kommissionen för behandling av vuxna med njursjukdomen IgA-nefropati, IgAN.
-
Medicon Valley Alliance
-
The new ZEISS Celldiscoverer 7 has been launched
Adaptable automation for advanced workflows.
-
Vertex betalar 52 miljarder för bolag inom autoimmuna sjukdomar
Amerikanska Vertex Pharmaceuticals köper biotechbolaget Alpine Immune Sciences för 4,9 miljarder dollar, motsvarande drygt 52 miljarder kronor.